Establishment of a desirable dose using neutral argon plasma to eradicate miliary peritoneal implants: A phase I/II controlled trial

ISSN
07487983
Date Issued
2023
Author(s)
DOI
10.1016/j.ejso.2023.07.004
Subjects

Oncology

Surgery